| Michelle M Hofmeister, | |
|
1575 N Rivercenter Dr, Milwaukee, WI 53212-3978 | |
| (414) 283-8444 | |
| Not Available |
| Full Name | Michelle M Hofmeister |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 10 Years |
| Location | 1575 N Rivercenter Dr, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053726026 | NPI | - | NPPES |
| 100085697 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 68920 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aurora Medical Group, Inc. | 6709794258 | 3207 |
| Lakeshore Medical Clinic Llc | 7719890730 | 300 |
News Archive
An experimental drug that boosts production of the immune system protein interferon worsens tuberculosis (TB) in mice, according to scientists from the National Institutes of Health. The drug acts indirectly by drawing certain immune cells, in which Mycobacterium tuberculosis (M.tb) bacteria thrive, to the lungs. The findings may have potential implications for the care of people infected with TB, the authors note. The research is reported in the May 3 issue of Journal of Clinical Investigation, now available online.
A shadow over the promising inhaled interferon beta COVID-19 therapy has been cleared with the discovery that although it appears to increase levels of ACE2 protein - coronavirus' key entry point into nose and lung cells - it predominantly increases levels of a short version of that protein, which the virus cannot bind to.
Nova Southeastern University is now at the forefront of conducting pioneering cell-based biomedical research with the launch of the new NSU Cell Therapy Institute, an international collaboration with prominent medical research scientists from Sweden's world-renowned Karolinska Institutet (KI).
A study in the January/February 2006 issue of the journal Health Affairsconcludes that increasing the number of registered nurses and hours of nursing care per patient would save 6,700 lives and 4 million days of patient care in hospitals each year.
› Verified 8 days ago
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
An experimental drug that boosts production of the immune system protein interferon worsens tuberculosis (TB) in mice, according to scientists from the National Institutes of Health. The drug acts indirectly by drawing certain immune cells, in which Mycobacterium tuberculosis (M.tb) bacteria thrive, to the lungs. The findings may have potential implications for the care of people infected with TB, the authors note. The research is reported in the May 3 issue of Journal of Clinical Investigation, now available online.
A shadow over the promising inhaled interferon beta COVID-19 therapy has been cleared with the discovery that although it appears to increase levels of ACE2 protein - coronavirus' key entry point into nose and lung cells - it predominantly increases levels of a short version of that protein, which the virus cannot bind to.
Nova Southeastern University is now at the forefront of conducting pioneering cell-based biomedical research with the launch of the new NSU Cell Therapy Institute, an international collaboration with prominent medical research scientists from Sweden's world-renowned Karolinska Institutet (KI).
A study in the January/February 2006 issue of the journal Health Affairsconcludes that increasing the number of registered nurses and hours of nursing care per patient would save 6,700 lives and 4 million days of patient care in hospitals each year.
› Verified 8 days ago
| Entity Name | Lakeshore Medical Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003861188 PECOS PAC ID: 7719890730 Enrollment ID: O20031106000481 |
News Archive
An experimental drug that boosts production of the immune system protein interferon worsens tuberculosis (TB) in mice, according to scientists from the National Institutes of Health. The drug acts indirectly by drawing certain immune cells, in which Mycobacterium tuberculosis (M.tb) bacteria thrive, to the lungs. The findings may have potential implications for the care of people infected with TB, the authors note. The research is reported in the May 3 issue of Journal of Clinical Investigation, now available online.
A shadow over the promising inhaled interferon beta COVID-19 therapy has been cleared with the discovery that although it appears to increase levels of ACE2 protein - coronavirus' key entry point into nose and lung cells - it predominantly increases levels of a short version of that protein, which the virus cannot bind to.
Nova Southeastern University is now at the forefront of conducting pioneering cell-based biomedical research with the launch of the new NSU Cell Therapy Institute, an international collaboration with prominent medical research scientists from Sweden's world-renowned Karolinska Institutet (KI).
A study in the January/February 2006 issue of the journal Health Affairsconcludes that increasing the number of registered nurses and hours of nursing care per patient would save 6,700 lives and 4 million days of patient care in hospitals each year.
› Verified 8 days ago
| Entity Name | Aurora Advanced Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265629133 PECOS PAC ID: 3375625833 Enrollment ID: O20080123000694 |
News Archive
An experimental drug that boosts production of the immune system protein interferon worsens tuberculosis (TB) in mice, according to scientists from the National Institutes of Health. The drug acts indirectly by drawing certain immune cells, in which Mycobacterium tuberculosis (M.tb) bacteria thrive, to the lungs. The findings may have potential implications for the care of people infected with TB, the authors note. The research is reported in the May 3 issue of Journal of Clinical Investigation, now available online.
A shadow over the promising inhaled interferon beta COVID-19 therapy has been cleared with the discovery that although it appears to increase levels of ACE2 protein - coronavirus' key entry point into nose and lung cells - it predominantly increases levels of a short version of that protein, which the virus cannot bind to.
Nova Southeastern University is now at the forefront of conducting pioneering cell-based biomedical research with the launch of the new NSU Cell Therapy Institute, an international collaboration with prominent medical research scientists from Sweden's world-renowned Karolinska Institutet (KI).
A study in the January/February 2006 issue of the journal Health Affairsconcludes that increasing the number of registered nurses and hours of nursing care per patient would save 6,700 lives and 4 million days of patient care in hospitals each year.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michelle M Hofmeister, Po Box 735044, Chicago, IL 60673-5044 Ph: () - | Michelle M Hofmeister, 1575 N Rivercenter Dr, Milwaukee, WI 53212-3978 Ph: (414) 283-8444 |
News Archive
An experimental drug that boosts production of the immune system protein interferon worsens tuberculosis (TB) in mice, according to scientists from the National Institutes of Health. The drug acts indirectly by drawing certain immune cells, in which Mycobacterium tuberculosis (M.tb) bacteria thrive, to the lungs. The findings may have potential implications for the care of people infected with TB, the authors note. The research is reported in the May 3 issue of Journal of Clinical Investigation, now available online.
A shadow over the promising inhaled interferon beta COVID-19 therapy has been cleared with the discovery that although it appears to increase levels of ACE2 protein - coronavirus' key entry point into nose and lung cells - it predominantly increases levels of a short version of that protein, which the virus cannot bind to.
Nova Southeastern University is now at the forefront of conducting pioneering cell-based biomedical research with the launch of the new NSU Cell Therapy Institute, an international collaboration with prominent medical research scientists from Sweden's world-renowned Karolinska Institutet (KI).
A study in the January/February 2006 issue of the journal Health Affairsconcludes that increasing the number of registered nurses and hours of nursing care per patient would save 6,700 lives and 4 million days of patient care in hospitals each year.
› Verified 8 days ago
Dr. Mary Grace Hernandez Lasquety, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2311 N Prospect Ave, Milwaukee, WI 53211 Phone: 414-319-3000 Fax: 414-319-3033 | |
Dr. Rodrigo Itable, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2745 W Layton Ave, Suite 201, Milwaukee, WI 53221 Phone: 414-281-0050 Fax: 414-281-0733 | |
Steven Bondow, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1155 N Mayfair Rd, Plank Road Clinic, Milwaukee, WI 53226 Phone: 414-955-5990 Fax: 414-955-6282 | |
Dr. Sabina Diehr, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1155 N Mayfair Rd, Plank Road Clinic, Milwaukee, WI 53226 Phone: 414-955-5990 Fax: 414-955-6282 | |
Luz Stella Moreno, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 637 W Mitchell St, Milwaukee, WI 53204 Phone: 414-383-8989 | |
Quentin Mattern, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2320 N Lake Dr, Room 3603, Milwaukee, WI 53211 Phone: 414-270-4932 | |
Jennifer Marie Markowski, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 3003 W Good Hope Rd, Milwaukee, WI 53209 Phone: 414-352-3100 |